Betoptic

Betoptic

betaxolol

Manufacturer:

Novartis Healthcare

Distributor:

Mundipharma
Concise Prescribing Info
Contents
Betaxolol HCl
Indications/Uses
Chronic open-angle glaucoma. Elevated IOP (ocular hypertensive patients). Glaucoma or ocular HTN w/ reactive airway disease; or is currently on multiple-antiglaucoma therapy.
Dosage/Direction for Use
1 drop in the affected eye(s) bid.
Contraindications
Hypersensitivity. Sinus bradycardia, 2nd or 3rd-degree AV block, overt cardiac failure or cardiogenic shock.
Special Precautions
Monitor patients w/ CV diseases (eg, CHD, Prinzmetal's angina & cardiac failure) for signs of deterioration; hypotension. Discontinue treatment at first sign of cardiac failure. Severe peripheral circulatory disturbance/disorders eg, severe forms of Raynaud's disease or syndrome. Bronchospasm in patients w/ asthma. Glaucoma patients w/ excessive restriction of pulmonary function. Spontaneous hypoglycaemia or labile diabetes. May mask signs & symptoms of acute hypoglycaemia & hyperthyroidism (eg, tachycardia). May potentiate muscle weakness w/ certain myasthenic symptoms (eg, diplopia, ptosis & generalized weakness). History of atopy or severe anaphylactic reactions to a variety of allergens. Consider gradual w/drawal prior to general anesth. Surgical anaesth. May block systemic β-agonist effects eg, adrenaline. May cause irritation & discolour soft contact lenses. Avoid contact w/ soft contact lenses. May impair ability to drive or use machines. Pregnancy & lactation.
Adverse Reactions
Ocular discomfort. Blurred vision, increased lacrimation; headache.
Drug Interactions
Hypotension &/or marked bradycardia w/ oral Ca channel blockers, β-adrenergic blocking agents, catecholamine-depleting drugs (eg, reserpine), antiarrhythmics including amiodarone, digitalis glycosides or adrenergic psychotropics. Potential additive effect on IOP w/ oral β-adrenergic blockers. Decrease response to adrenaline.
ATC Classification
S01ED02 - betaxolol ; Belongs to the class of beta blocking agents. Used in the treatment of glaucoma.
Presentation/Packing
Form
Betoptic eye drops 0.5%
Packing/Price
5 mL x 1's (P466.58/container)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in